📰 Beigene News
Page 19 - Beigene News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Beigene. Real-time updates on events, politics, business and more.
April 8, 2022
Results from subanalyses of RATIONALE-303 and -304 add to the growing body of data on tislelizumab as a potential treatment for non-small cell lung cancer Biomarker studies shed light on patient
March 27, 2022
LVW Advisors LLC lowered its stake in BeiGene, Ltd. (NASDAQ:BGNE – Get Rating) by 9.7% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 1,799 shares of the company’s stock after selling 193 shares during the period. LVW Advisors LLC’s holdings in BeiGene were worth $487,000 […]
March 23, 2022
The plan relegates the CSRC to the back seat in the auditing dispute between the US and China, from the role it has held since 2016 as the collector and gatekeeper of China’s audit working papers.
March 18, 2022
Eisai has decided to exit its supporting role for Biogen's Alzheimer's drug Aduhelm. Chinese companies including several biotechs face potential U.S.
March 17, 2022
BeiGene (NASDAQ:BGNE – Get Rating) was downgraded by research analysts at SVB Leerink from an “outperform” rating to a “market perform” rating in a research report issued on Thursday, Briefing.com reports. They currently have a $177.00 price target on the stock, down from their previous price target of $300.00. SVB Leerink’s price target points to […]
March 15, 2022
15.03.2022 - BeiGene (NASDAQ: BGNE; HKEX: 06160, SSE: 688235), a global, science-driven biotechnology company focused on developing innovative and affordable medicines to improve treatment outcomes and access for patients worldwide, and Medison Pharma Ltd. a ... Seite 1
March 14, 2022
Shares of Chinese stocks listed in the U.S. tumbled Monday as investors reassess their positions amid renewed delisting fears
March 11, 2022
The stocks were the first of 270 identified by the SEC on a list of New York-listed companies liable to the Holding Foreign Companies Accountable Act (HFCAA), which took effect on December 18, 2020.
March 11, 2022
The S.E.C. specified five U.S.-traded Chinese companies required to turn over audit information to regulators. The news reverberated in Asian markets Friday.